483 related articles for article (PubMed ID: 20884085)
1. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
2. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
Lin KW; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Jul; 19(14):4274-85. PubMed ID: 21696969
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
4. A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides.
Schwarz S; Siewert B; Xavier NM; Jesus AR; Rauter AP; Csuk R
Eur J Med Chem; 2014 Jan; 72():78-83. PubMed ID: 24361520
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
9. Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Mar; 345(3):223-30. PubMed ID: 21997717
[TBL] [Abstract][Full Text] [Related]
10. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2011 Aug; 344(8):505-13. PubMed ID: 21674592
[TBL] [Abstract][Full Text] [Related]
13. N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
Lallemand B; Chaix F; Bury M; Bruyère C; Ghostin J; Becker JP; Delporte C; Gelbcke M; Mathieu V; Dubois J; Prévost M; Jabin I; Kiss R
J Med Chem; 2011 Oct; 54(19):6501-13. PubMed ID: 21888390
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791593
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor evaluation of panaxadiol derivatives.
Liu XK; Ye BJ; Wu Y; Lin ZH; Zhao YQ; Piao HR
Eur J Med Chem; 2011 Jun; 46(6):1997-2002. PubMed ID: 21439693
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells.
Leal AS; Wang R; Salvador JA; Jing Y
Org Biomol Chem; 2013 Feb; 11(10):1726-38. PubMed ID: 23381885
[TBL] [Abstract][Full Text] [Related]
17. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel α-santonin derivatives as potential cytotoxic agents.
Arantes FF; Barbosa LC; Maltha CR; Demuner AJ; Marçal da Costa P; Ferreira JR; Costa-Lotufo LV; Moraes MO; Pessoa C
Eur J Med Chem; 2010 Dec; 45(12):6045-51. PubMed ID: 20971532
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
